- Statins and dilated cardiomyopathy: do we have enough data?
[作者:Bielecka-Dabrowa, A; Mikhailidis, DP; Hannam, S; Aronow, WS; Rysz, J; Banach, M,期刊:Expert opinion on investigational drugs, 页码:315-323 , 文章类型: Review,,卷期:2011年20-3]
- Areas covered: Several lines of evidence suggest that inflammation plays a role in the development and progression of CHF, influencing heart contractility and hypertrophy, promoting apoptosis and contributing to myocardi...
- Therapeutic intervention for Alzheimer's disease with gamma gamma-secretase inhibitors: still a viable option?
[作者:Imbimbo, BP; Panza, F; Frisardi, V; Solfrizzi, V; D'Onofrio, G; Logroscino, G; Seripa, D; Pilotto, A,期刊:Expert opinion on investigational drugs, 页码:325-341 , 文章类型: Review,,卷期:2011年20-3]
- Areas covered: This article briefly reviews the profile of gamma gamma-secretase inhibitors that have reached the clinic and discusses the clinical issues surrounding this new class of anti-AD compounds. Expert opinion: ...
- Novel I kappa kappa B kinase inhibitors for treatment of nuclear factor-kappa kappa B-related diseases
[作者:Suzuki, J; Ogawa, M; Muto, S; Itai, A; Isobe, M; Hirata, Y; Nagai, R,期刊:Expert opinion on investigational drugs, 页码:395-405 , 文章类型: Review,,卷期:2011年20-3]
- Areas covered: NF-kappa kappa B affects the progression of inflammation-related diseases, such as myocardial ischemia, bronchial asthma, arthritis, cancer and other diseases. We review the characteristics and effects of ...
- XL184 (cabozantinib) for medullary thyroid carcinoma
[作者:Durante, C; Russo, D; Verrienti, A; Filetti, S,期刊:Expert opinion on investigational drugs, 页码:407-413 , 文章类型: Editorial Material,,卷期:2011年20-3]
- Areas covered: We review preliminary data on the safety and efficacy of XL184 in metastatic MTC based on an extensive search of the literature, which included published articles, abstracts and website information. In par...
|